This will be my post in response to the NY Times' series on Suboxone. This post originally ran on 7/19/13 and addressed a lot of our concerns. * * * I've been catching a lot of heat recently for posts about Suboxone and methadone. (For the sake of this post, lets refer to … Continue reading What makes treatment effective?
To me, the most important line in the NY Times Suboxone series was this one, "[Dr. Sullivan] considered opioid addiction "a hopeless disease'". We believe that maintenance approaches are rooted in the belief that most opiate addicts are not capable of recovering in the same manner that doctors recover. Most of the arguments for maintenance treatments … Continue reading no hint of opinion here
Drug and Alcohol Findings reviews research on the impact of counseling for methadone patients. While across the board there was significant improvement, being assigned to standard/enhanced versus interim (no counseling) programmes did not further improve retention, illicit drug use and related problems, or make much difference to criminal activity. There was no evidence that interim … Continue reading Methadone with and without counseling
The following abstract popped up today. The purpose of the study was to look at factors associated with completion of the 6 month, primary care based program. What struck me was the completion rate--35.7%. For all the crowing about ORT, this seems really low. (And, they said this completion rate is consistent with prior studies.) … Continue reading Buprenorphine compliance rates
Ian McLoone directs us to another study (the 4th in a row) finding that buprenorphine patients receive no benefit from added behavioral treatments. Where does this leave us? We've seen criticism of the devolution of methadone maintenance (MMT) into dosing clinics with calls for a new recovery orientation to MMT and a return to methadone being … Continue reading Buprenorphine + therapy = ?
I've been catching a lot of heat recently for posts about Suboxone and methadone. (For the sake of this post, lets refer to them as opioid replacement therapy, or ORT, for the rest of this post. One commenter who blogs for an ORT provider challenged my arguments that we should offer everyone the same kind … Continue reading What makes treatment effective?
Mark Kleiman, the Washington state pot czar, explains his use of "scare quotes" when writing about medical marijuana: Yes, cannabis has medical value for some people. And yes, the sustained effort of the federal government to make medical cannabis research as difficult as possible is a national disgrace. And then, on the other … Continue reading Why “medical” marijuana gets little respect here
From an article about a new report on medications for opiate treatment: The report also examined studies that evaluated buprenorphine, methadone, injectable naltrexone, and oral naltrexone and concluded a benefit in patient outcomes as well as costs. "I can say with no hint of opinion here, it's simple fact, they are all effective," McLellan said. … Continue reading no hint of opinion here
Cochrane conducts a meta-analysis of motivational interviewing (MI) and concludes that it's no more effective than other treatments. More than 76 million people worldwide have alcohol problems, and another 15 million have drug problems. Motivational interviewing (MI) is a psychological treatment that aims to help people cut down or stop using drugs and alcohol. The … Continue reading Motivational Interviewing works, but no better than other treatments
From Alcoholism and Drug Abuse Weekly: In September, when Tennessee-based Acadia Healthcare Company paid $90 million for Timberline Knolls, a 122-bed inpatient treatment program in Chicago, treatment providers wondered if their programs were worth that kind of money, bed for bed. Other deals in recent months, including Foundations Recovery Network’s acquisition in early October by … Continue reading Treatment is big money